References - - BioPharm International

ADVERTISEMENT

References


BioPharm International


BOOKSAhern TJ, Manning M, eds. Stability of protein pharmaceuticals, part A: chemical and physical pathways of protein degradation. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Ahern TJ, Manning M, eds. Stability of protein pharmaceuticals, part B: in vivo pathways of degradation and strategies for protein stabilization. Pharmaceutical biotechnology series, volume 2. New York: Plenum Press; 1992.

Avis KE, Wu VL. Biotechnology and biopharmaceutical manufacturing, processing, and preservation. Drug manufacturing technology series, volume 2. Buffalo Grove (IL):Interpharm Press; 1996.

Banga AK. Electrically assisted transdermal and topical drug delivery. London: Taylor & Francis; 1998.

Bontempo J, ed. Development of biopharmaceutical parenteral dosage forms. New York: Marcel Dekker; 1997.

Carpenter, JF, Chang BS, Garzon-Rodriguez W, Randolph TW. Rational design of stabilized lyophilized protein formulations: theory and practice. In: Carpenter JF, Manning MC, editors. Rational design of stable protein formulations: theory and practice. New York: Kluwer/Plenum Press; 2002. p. 109-133.

DeSain C. Documentation basics that support good manufacturing practices. Cleveland (OH): Advanstar Communications; 1993.

Hider RC, Barlow D. Polypeptide and protein drugs: production, characterization, and formulation. Ellis Horwood Ltd: Chichester UK; 1991.

Huxsoll JF. Quality assurance for biopharmaceuticals. New York: John Wiley & Sons; 1994.

Kibbe AH, ed. Handbook of pharmaceutical excipients. Third Ed. Washington, DC: American Pharmaceutical Association; 2000.

McNally EJ, ed. Protein formulation and delivery. New York: Marcel Dekker; 2000.

Rowe RC, Roberts RJ. Intelligent software for product formulation. London: Taylor & Francis; 1998.

Saeb-Parsy K, et al., eds. Instant pharmacology. New York: John Wiley & Sons; 1999.

Wang YJ, Pearlman R, eds. Stability and characterization of protein and peptide drugs: case histories. Pharmaceutical biotechnology series, volume 5. New York: Plenum Press; 1993.

Wang YJ, Pearlman R, eds. Formulation, characterization, and stability of protein drugs: case histories. Pharmaceutical biotechnology series, volume 9. New York: Plenum Press; 1996.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

NIH Launches Human Safety Study of Ebola Vaccine Candidate
August 29, 2014
Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
USP Awards Analytical Research
August 15, 2014
Author Guidelines
Source: BioPharm International,
Click here